Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Corey

Showing results (101-110 of 154) with videos related to

Pageof 16
Sort By:
International Journal of Antimicrobial Agents|September 26, 2016
Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureusG Ralph Corey, Francis F Arhin, Matthew A Wikler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2005
Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged DatabaseJosé M Miro, Ignasi Anguera, Christopher H Cabell, et al.
The American Journal of Medicine|March 11, 2009
Staphylococcus aureus bacteremia among patients with health care-associated feverMartin E Stryjewski, Zeina A Kanafani, Vivian H Chu, et al.
Journal of Clinical Microbiology|December 14, 2007
Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infectionsSteven J Campbell, Hitesh S Deshmukh, Charlotte L Nelson, et al.
Infection Control and Hospital Epidemiology|July 16, 2005
Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysisJohn J Engemann, Joelle Y Friedman, Shelby D Reed, et al.
The American Journal of Cardiology|September 29, 2005
Clinical characteristics and outcome of aortic endocarditis with periannular abscess in the International Collaboration on Endocarditis Merged DatabaseIgnasi Anguera, Jose M Miro, Christopher H Cabell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremiaMartin E Stryjewski, Lynda A Szczech, Daniel K Benjamin, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 studyMartin E Stryjewski, Vivian H Chu, William D O'Riordan, et al.
Scandinavian Journal of Infectious Diseases|July 11, 2008
Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infectionsTahaniyat Lalani, Vivian H Chu, Chelsea A Grussemeyer, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)Thomas L Holland, William O'Riordan, Alison McManus, et al.
Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
International Journal of Antimicrobial Agents|September 26, 2016
Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureusG Ralph Corey, Francis F Arhin, Matthew A Wikler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2005
Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged DatabaseJosé M Miro, Ignasi Anguera, Christopher H Cabell, et al.
The American Journal of Medicine|March 11, 2009
Staphylococcus aureus bacteremia among patients with health care-associated feverMartin E Stryjewski, Zeina A Kanafani, Vivian H Chu, et al.
Journal of Clinical Microbiology|December 14, 2007
Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infectionsSteven J Campbell, Hitesh S Deshmukh, Charlotte L Nelson, et al.
Infection Control and Hospital Epidemiology|July 16, 2005
Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysisJohn J Engemann, Joelle Y Friedman, Shelby D Reed, et al.
The American Journal of Cardiology|September 29, 2005
Clinical characteristics and outcome of aortic endocarditis with periannular abscess in the International Collaboration on Endocarditis Merged DatabaseIgnasi Anguera, Jose M Miro, Christopher H Cabell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremiaMartin E Stryjewski, Lynda A Szczech, Daniel K Benjamin, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 studyMartin E Stryjewski, Vivian H Chu, William D O'Riordan, et al.
Scandinavian Journal of Infectious Diseases|July 11, 2008
Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infectionsTahaniyat Lalani, Vivian H Chu, Chelsea A Grussemeyer, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)Thomas L Holland, William O'Riordan, Alison McManus, et al.
Pageof 16